BridgeMD
New treatment option for Dementia
Official title The Exercogs® Study
ClinicalTrials.gov ID: NCT07530315
What this study is testing
- What it's testing
- Background: Multidomain, technology-based interventions represent a promising approach to dementia prevention by simultaneously targeting cognitive, physical, and social domains. Exercogs® is a novel exergaming platform combining augmented reality (AR) and gamification, designed to deliver tailored, interactive, and multidomain training.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older
You may be able to join if
- Age 55 years or older
- Presence of ≥1 modifiable risk factor according to the Lancet Commission on Dementia Prevention, Intervention, and Care (2024): low education...
- Ability and willingness to participate in 60-minute sessions, three times per week, during the 24-week intervention period;
- Ability to provide written informed consent, or, in cases of reduced decisional capacity, provision of consent by a legally authorized representative.
You likely can't join if
- Clinical diagnosis of Alzheimer's disease or dementia;
- Severe neurological disorder or unstable medical condition that may interfere with participation;
- Sensory or language deficits that would prevent understanding of instructions or safe participation;
- Current participation in another treatment study that may confound outcomes (e.g., cognitive training, physical exercise, or multidomain...
- Previous experience with Exercogs®.
The study team makes the final eligibility decision.
Where it's taking place
- Sintra, Portugal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sintra, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.